phase readout
saveNCT07223229: Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
RECRUITINGupdated 2d ago
community read0 votes
Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.. Phase: PHASE2. Conditions: Non-segmental Vitiligo
view source ↗
comments(0)
5-min edit window · permanent after that